Compare ProShares Bitcoin ETF (BITO) vs Medpace Holdings Inc (MEDP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ProShares Bitcoin ETF vs Medpace Holdings Inc — how do they compare? ProShares Bitcoin ETF trades at $8.56, while Medpace Holdings Inc trades at $599.51 (market cap $16.90B). The key difference: Medpace Holdings Inc is trading nearer its 52-week high, ProShares Bitcoin ETF nearer its low. Which is the better fit depends on your goals.
| BITO | MEDP | |
|---|---|---|
Sector | Crypto-linked | Technology |
52-Week High | $22.27 | $620.59 |
52-Week Low | $7.98 | $393.42 |
Market Cap | — | $16.90B |
Enterprise Value | — | $16.52B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BITO trades at $8.64 with no recent price movement, showing technical bearish signals from moving averages while oscillators remain neutral. The ETF faces headwinds as recent analysis highlights underperformance compared to spot Bitcoin ETFs, with Seeking Alpha maintaining a Sell rating for retail investors. Dividend distributions of $0.01 per share provide modest income but haven't offset significant price declines over the past year.
The outlook remains challenging with institutional sentiment turning cautious amid crypto market volatility. Key risks include high fee structures, competitive pressure from newer spot Bitcoin ETFs, and correlation breakdowns with traditional risk assets. Analyst consensus leans bearish given the fund's structural disadvantages and ongoing crypto winter conditions.
MEDP trades at $600.32, down 0.35% on the day, with a bullish technical signal supported by moving averages. The stock shows strong fundamentals with Q2 2026 earnings beating estimates at $4.25 per share versus $3.98 expected, and revenue growth projected from $2.53B in 2025 to $2.8B in 2026. Recent news highlights record bookings and raised guidance, though valuation ratios remain elevated with a P/E of 35.58 and P/B of 38.95.
Outlook remains positive driven by earnings momentum and strong backlog visibility, but risks include premium valuation compression and ongoing legal scrutiny. Analyst consensus is cautious with 73.7% hold ratings, though institutional interest persists with California State Teachers Retirement System increasing its position by 22.1% in Q1 2026.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ProShares Bitcoin ETF
BITO offers exposure to Bitcoin returns primarily through Bitcoin futures contracts. It provides a regulated way for investors to trade Bitcoin performance within a traditional brokerage account without direct ownership.
Read more on BITO →About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →
